Last reviewed · How we verify
NCT04660526
RACE-CARS - RAndomized Cluster Evaluation of Cardiac ARrest Systems
NA trial testing Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators in Cardiac Arrest in 20,000 participants. Enrolling by invitation.
30 June 2027
Quick facts
| Lead sponsor | Duke University |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 20,000 |
| Start date | 1 July 2022 |
| Primary completion | 30 June 2027 |
| Estimated completion | 30 June 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators
- Systematic bystander resuscitation instruction by 911 operators
- Comprehensive community training of lay people in CPR and AED use.
- Optimized first responder performance including earlier use of AEDs.
Conditions studied
- Cardiac Arrest — all drugs for Cardiac Arrest →
Sponsor
Duke University
Who can join
18 and older, any sex, with Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
RACE-CARS is a real-world cluster-randomized trial designed to evaluate a multifaceted community and health systems intervention aimed to improve outcomes of out-of-hospital cardiac arrest. RACE-CARS will enroll 50 counties in North Carolina that are estimated to have a total of approximately 20,000 patients with cardiac arrest over a 4-year intervention period. County "clusters" will be randomized in a 1:1 ratio to intervention versus usual care. The trial duration is 7 years, which includes a 6-month start-up (including recruitment and randomization) period, a 12-month intervention training phase, a 4-year intervention period, a 12-month follow-up for to assess quality of life in survivors of OHCA, and a 6-month close-out and data analysis period.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
International Consensus on Evidence Gaps and Research Opportunities in Extracorporeal Cardiopulmonary Resuscitation for Refractory Out-of-Hospital Cardiac Arrest: A Report From the National Heart, Lung, and Blood Institute Workshop.
Morrison LJ, Hunt EA, Grunau B, Aufderheide TP, et al · · 2025 · cited 9× · PMID 40040619 · DOI 10.1161/jaha.124.036108 -
RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and design.
Krychtiuk KA, Starks MA, Al-Khalidi HR, Mark DB, et al · · 2024 · cited 3× · PMID 39084483 · DOI 10.1016/j.ahj.2024.07.013 -
Public awareness of automated external defibrillator (AED)s and their location: Results of a cross-sectional survey in North Carolina.
Yonis H, Kaltenbach LA, Nouhravesh N, Mark D, et al · · 2025 · PMID 40034874 · DOI 10.1016/j.resplu.2025.100897
Verify or expand the search:
- PubMed search for NCT04660526
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Arrest
Currently open trials in the same condition.
- NCT07239206 — Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses · NA · recruiting
- NCT06780722 — Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Proced · recruiting
- NCT06405581 — The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation · recruiting
- NCT06511999 — Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest · recruiting
- NCT07113769 — Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation · recruiting
Other Duke University trials
Trials by the same sponsor.
- NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
- NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
- NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
- NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
- NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04660526 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Duke University
- Last refreshed: 30 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04660526.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing